Skip to main content
Erschienen in: Journal of Nephrology 3/2019

01.06.2019 | Original Article

Aortic pulse wave velocity is greater in peritoneal dialysis patients with lower dual energy X-ray absorptiometry (DXA) femoral neck bone mineral density

verfasst von: Kamonwan Tangvoraphonkchai, Andrew Davenport

Erschienen in: Journal of Nephrology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Increased vascular stiffness is associated with low bone mineral density (BMD) in the general population, and both are risk factors for mortality. We wished to determine whether vascular stiffness is associated with BMD in peritoneal dialysis (PD) patients.

Methods

We measured vascular stiffness by aortic pulse wave velocity (aPWV), BMD by dual electron absorptiometry (DXA) scanning, and body composition using bioimpedance.

Results

We reviewed DXA scans in 125 PD patients, 56.8% male, mean age 64.4 ± 15.3 years, mean aPWV, 10.2 ± 2.6 m/s. We divided patients by aPWV (< 10 and > 10 m/s), and there were no statistical differences in patient demographics, body composition, PD adequacy, peritoneal and urinary calcium losses. On univariate analysis aPWV was negatively associated with total body T score (r = − 0.20, p = 0.037). On multivariable logistic regression patients with higher aPWV were prescribed fewer non-calcium containing phosphate binders, odds ratio (OR) 0.83, 95% confidence interval (CI) 0.70–0.99, p = 0.039, more had lower 25 hydroxy-vitamin D3 concentrations < 50 ng/L (OR 0.34, CI 0.12–0.93, p = 0.035, and lower femoral BMD OR 0.03 (CI 0–0.3.4), p = 0.029, but there was no association with total or lumbar spine BMD.

Conclusion

Our study reinforces the hypothesis of a link between bone disease and vascular disease in dialysis patients. As patients with higher aPWV were prescribed fewer non-calcium containing phosphate binders and fewer had higher 25 hydroxy-vitamin D3 concentrations, then this raises the possibility that differences in clinical practice and drug prescribing may help to reduce vascular stiffness, which will require testing in future trials.
Literatur
1.
Zurück zum Zitat Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR (2005) Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20(11):1912–1920CrossRef Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR (2005) Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20(11):1912–1920CrossRef
2.
Zurück zum Zitat Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH (2011) Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 57(14):1511–1522CrossRef Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH (2011) Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 57(14):1511–1522CrossRef
3.
Zurück zum Zitat Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2008) Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 23(2):586–593CrossRef Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2008) Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 23(2):586–593CrossRef
4.
Zurück zum Zitat Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2009) Relationship between vascular calcification, arterial stiffness and bone mineral density in a cross-sectional study of prevalent Australian haemodialysis patients. Nephrology 14:105–109CrossRef Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2009) Relationship between vascular calcification, arterial stiffness and bone mineral density in a cross-sectional study of prevalent Australian haemodialysis patients. Nephrology 14:105–109CrossRef
5.
Zurück zum Zitat Adragao T, Branco P, Birne R, Curto JD, de Almeida E, Prata MM, Pais MJ (2008) Bone mineral density, vascular calcifications, and arterial stiffness in peritoneal dialysis patients. Perit Dial Int 28(6):668–672PubMed Adragao T, Branco P, Birne R, Curto JD, de Almeida E, Prata MM, Pais MJ (2008) Bone mineral density, vascular calcifications, and arterial stiffness in peritoneal dialysis patients. Perit Dial Int 28(6):668–672PubMed
6.
Zurück zum Zitat Kumar V, Yadav AK, Singhal M, Kumar V, Lal A, Banerjee D, Gupta KL, Jha V (2018) Vascular function and cholecalciferol supplementation in CKD: a self-controlled case series. J Steroid Biochem Mol Biol 180:19–22CrossRef Kumar V, Yadav AK, Singhal M, Kumar V, Lal A, Banerjee D, Gupta KL, Jha V (2018) Vascular function and cholecalciferol supplementation in CKD: a self-controlled case series. J Steroid Biochem Mol Biol 180:19–22CrossRef
7.
Zurück zum Zitat Udo A, Goodlad C, Davenport A (2017) Impact of diabetes on extracellular volume status in patients initiating peritoneal dialysis. Am J Nephrol 46(1):18–25CrossRef Udo A, Goodlad C, Davenport A (2017) Impact of diabetes on extracellular volume status in patients initiating peritoneal dialysis. Am J Nephrol 46(1):18–25CrossRef
8.
Zurück zum Zitat Fürstenberg A, Davenport A (2011) Assessment of body composition in peritoneal dialysis patients using bioelectrical impedance and dual-energy X-ray absorptiometry. Am J Nephrol 33(2):150–156CrossRef Fürstenberg A, Davenport A (2011) Assessment of body composition in peritoneal dialysis patients using bioelectrical impedance and dual-energy X-ray absorptiometry. Am J Nephrol 33(2):150–156CrossRef
9.
Zurück zum Zitat Horváth IG, Németh A, Lenkey Z, Alessandri N, Tufano F, Kis P, Gaszner B, Cziráki A (2010) Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens 28(10):2068–2075CrossRef Horváth IG, Németh A, Lenkey Z, Alessandri N, Tufano F, Kis P, Gaszner B, Cziráki A (2010) Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens 28(10):2068–2075CrossRef
10.
Zurück zum Zitat Davies JM, Bailey MA, Griffin KJ, Scott DJ (2012) Pulse wave velocity and the non-invasive methods used to assess it: Complior, SphygmoCor, Arteriograph and Vicorder. Vascular 20(6):342–349CrossRef Davies JM, Bailey MA, Griffin KJ, Scott DJ (2012) Pulse wave velocity and the non-invasive methods used to assess it: Complior, SphygmoCor, Arteriograph and Vicorder. Vascular 20(6):342–349CrossRef
11.
Zurück zum Zitat The Reference Values for Arterial Stiffness’ Collaboration (2010) Determinants of pulse wave velocity in healthypeople and in the presence of cardiovascular riskfactors: ‘establishing normal and reference values’ Eur Heart J 31:2338–2350CrossRef The Reference Values for Arterial Stiffness’ Collaboration (2010) Determinants of pulse wave velocity in healthypeople and in the presence of cardiovascular riskfactors: ‘establishing normal and reference values’ Eur Heart J 31:2338–2350CrossRef
12.
Zurück zum Zitat Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O’Donnell CJ, Wilson PW (2001) Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif Tissue Int 68(5):271–276CrossRef Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O’Donnell CJ, Wilson PW (2001) Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif Tissue Int 68(5):271–276CrossRef
13.
Zurück zum Zitat McFarlane SI, Muniyappa R, Shin RJJ, Bahtiyar G, Sowers JR (2004) Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine 23(1):1–10CrossRef McFarlane SI, Muniyappa R, Shin RJJ, Bahtiyar G, Sowers JR (2004) Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine 23(1):1–10CrossRef
14.
Zurück zum Zitat Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2010) Using vertebral bone densitometry to determine aortic calcification in patients with chronic kidney disease. Nephrology 15:575–583CrossRef Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2010) Using vertebral bone densitometry to determine aortic calcification in patients with chronic kidney disease. Nephrology 15:575–583CrossRef
15.
Zurück zum Zitat Fürstenberg A, Buscombe J, Davenport A (2010) Overestimation of lumbar spine calcium with dual energy X-ray absorptiometry scanning due to the prescription of lanthanum carbonate in patients with chronic kidney disease. Am J Nephrol 32(5):425–431CrossRef Fürstenberg A, Buscombe J, Davenport A (2010) Overestimation of lumbar spine calcium with dual energy X-ray absorptiometry scanning due to the prescription of lanthanum carbonate in patients with chronic kidney disease. Am J Nephrol 32(5):425–431CrossRef
16.
Zurück zum Zitat Aleksova J, Kurniawan S, Vucak-Dzumhur M, Kerr P, Ebeling PR, Milat F, Elder GJ (2018) Aortic vascular calcification is inversely associated with the trabecular bone score in patients receiving dialysis. Bone 113:118–123CrossRef Aleksova J, Kurniawan S, Vucak-Dzumhur M, Kerr P, Ebeling PR, Milat F, Elder GJ (2018) Aortic vascular calcification is inversely associated with the trabecular bone score in patients receiving dialysis. Bone 113:118–123CrossRef
17.
Zurück zum Zitat Raggi P, Bellasi A, Ferramosca E, Block GA, Muntner P (2007) Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients. Hypertension 49(6):1278–1284CrossRef Raggi P, Bellasi A, Ferramosca E, Block GA, Muntner P (2007) Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients. Hypertension 49(6):1278–1284CrossRef
18.
Zurück zum Zitat Jannot M, Mac-Way F, Lapierre V, Lafage-Proust MH (2017) The use of bone mineral density measured by dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed microtomography in chronic kidney disease. J Nephrol 30(5):635–664CrossRef Jannot M, Mac-Way F, Lapierre V, Lafage-Proust MH (2017) The use of bone mineral density measured by dual energy X-ray absorptiometry (DXA) and peripheral quantitative computed microtomography in chronic kidney disease. J Nephrol 30(5):635–664CrossRef
19.
Zurück zum Zitat Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96:1755–1760CrossRef Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96:1755–1760CrossRef
20.
Zurück zum Zitat Lim K, Hamano T, Thadhani R (2018) Vitamin D and calcimimetics in cardiovascular disease. Semin Nephrol 38(3):251–266CrossRef Lim K, Hamano T, Thadhani R (2018) Vitamin D and calcimimetics in cardiovascular disease. Semin Nephrol 38(3):251–266CrossRef
21.
Zurück zum Zitat Hénaut L, Chillon JM, Kamel S, Massy ZA (2018) Updates on the mechanisms and the care of cardiovascular calcification in chronic kidney disease. Semin Nephrol 38(3):233–250CrossRef Hénaut L, Chillon JM, Kamel S, Massy ZA (2018) Updates on the mechanisms and the care of cardiovascular calcification in chronic kidney disease. Semin Nephrol 38(3):233–250CrossRef
22.
Zurück zum Zitat Lips P, Goldsmith D, de Jongh R (2017) Vitamin D and osteoporosis in chronic kidney disease. J Nephrol 30(5):671–675CrossRef Lips P, Goldsmith D, de Jongh R (2017) Vitamin D and osteoporosis in chronic kidney disease. J Nephrol 30(5):671–675CrossRef
23.
Zurück zum Zitat Charitaki E, Davenport A (2014) Aortic pulse wave velocity in haemodialysis patients is associated with the prescription of active vitamin D analogues. J Nephrol 27(4):431–437CrossRef Charitaki E, Davenport A (2014) Aortic pulse wave velocity in haemodialysis patients is associated with the prescription of active vitamin D analogues. J Nephrol 27(4):431–437CrossRef
25.
Zurück zum Zitat LeBoeuf A, Mac-Way F, Utescu MS, De Serres SA, Douville P, Desmeules S, Lebel M, Agharazii M (2011) Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis. Nephrol Dial Transplant 26(11):3695–3701CrossRef LeBoeuf A, Mac-Way F, Utescu MS, De Serres SA, Douville P, Desmeules S, Lebel M, Agharazii M (2011) Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis. Nephrol Dial Transplant 26(11):3695–3701CrossRef
26.
Zurück zum Zitat Bover J, Bailone L, López-Báez V, Benito S, Ciceri P, Galassi A, Cozzolino M (2017) Osteoporosis, bone mineral density and CKD-MBD: treatment considerations. J Nephrol 30(5):677–687CrossRef Bover J, Bailone L, López-Báez V, Benito S, Ciceri P, Galassi A, Cozzolino M (2017) Osteoporosis, bone mineral density and CKD-MBD: treatment considerations. J Nephrol 30(5):677–687CrossRef
27.
Zurück zum Zitat Mazzaferro S, Massy ZA, Vervloet M, Cozzolino M (2017) Bone in CKD: why the ERA EDTA CKD-MBD working group organized a dedicated meeting? J Nephrol 30(5):621–622CrossRef Mazzaferro S, Massy ZA, Vervloet M, Cozzolino M (2017) Bone in CKD: why the ERA EDTA CKD-MBD working group organized a dedicated meeting? J Nephrol 30(5):621–622CrossRef
Metadaten
Titel
Aortic pulse wave velocity is greater in peritoneal dialysis patients with lower dual energy X-ray absorptiometry (DXA) femoral neck bone mineral density
verfasst von
Kamonwan Tangvoraphonkchai
Andrew Davenport
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Journal of Nephrology / Ausgabe 3/2019
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-018-0551-x

Weitere Artikel der Ausgabe 3/2019

Journal of Nephrology 3/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.